YOUR BUSINESS AUTHORITY
Springfield, MO
Eli Lilly has agreed to buy gene-editing startup Verve Therapeutics.
The deal is valued at up to $1.3 billion.
The agreement calls for an upfront payment of $1 billion, and $300 million will be paid out based on the completion of certain clinical milestones.
Read more from CNBC.
A provider of hyperbaric oxygen therapy opened its first Missouri location on Aug. 12 at 1316 E. Republic Road.